Ondine Biomedical Inc.
OBIMF
$0.14
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.12M | -15.42M | -13.92M | -12.26M | -10.54M |
| Total Depreciation and Amortization | 423.40K | 415.20K | 412.50K | 415.70K | 417.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 836.80K | 826.00K | 822.60K | 536.00K | 242.10K |
| Change in Net Operating Assets | 2.55M | 1.96M | 1.38M | 1.00M | 603.90K |
| Cash from Operations | -13.31M | -12.22M | -11.30M | -10.31M | -9.27M |
| Capital Expenditure | -17.10K | -12.10K | -7.40K | -8.50K | -9.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -17.10K | -12.10K | -7.40K | -8.50K | -9.60K |
| Total Debt Issued | 1.65M | 1.65M | 1.65M | 826.00K | -- |
| Total Debt Repaid | -958.00K | -961.00K | -964.00K | -702.00K | -440.00K |
| Issuance of Common Stock | 22.69M | 22.84M | 22.98M | 16.98M | 10.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.40M | -1.67M | -1.93M | -1.59M | -1.25M |
| Cash from Financing | 15.83M | 15.77M | 15.80M | 11.39M | 6.85M |
| Foreign Exchange rate Adjustments | 589.20K | 492.20K | 399.40K | 231.20K | 58.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.10M | 4.03M | 4.89M | 1.30M | -2.37M |